EUVIMEDEUVIMED entdecken
Crossref

Plasma cell-free DNA in patients with acute promyelocytic leukaemia treated with arsenic trioxide

Junko Fujihara iD, Naoki Nishimoto iD, Haruo Takeshita

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · 2024

DOI: 10.1177/00045632231216596 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2024. Verfasst von Junko Fujihara und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Legal Medicine, Shimane University Faculty of Medicine, Izumo, Japan. Hauptthemen laut MEDLINE: Arsenic Trioxide, Leukemia, Promyelocytic, Acute, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cell-free DNA (cfDNA) is free DNA found in circulating blood that originates from apoptosis or necrosis, and elevated cfDNA concentrations have been reported in cancers and other diseases.

Methods

In this study, the concentrations and fragment distributions of plasma cfDNA were preliminary investigated in elderly ( n = 1) and paediatric ( n = 1) patients with acute promyelocytic leukaemia (APL) treated with arsenic trioxide (ATO).

Results

A slight increase in cfDNA concentrations was observed in the APL patients compared with healthy controls. The change in plasma cfDNA concentrations corresponded to the change in plasma arsenic concentrations during ATO treatment. The fragment distribution pattern did not differ before and during treatment. Three ladder fragments were observed in part of the cfDNA in the second consolidation therapy in an elderly APL patient and the first consolidation therapy of a paediatric APL patient, while two fragments were observed in all other treatment periods. Moreover, APL-related gene mutations were successfully genotyped from plasma cfDNA by using polymerase chain reaction-based methods and these results are consistent with those from leukocytes.

Conclusion

This study is the first to report the concentrations and fragment patterns of cfDNA from APL patients treated with ATO. The results suggested that plasma cfDNA concentration in APL patients increased with ATO treatment and that cfDNA is released mainly via neutrophil extracellular traps (and/or necrosis) in addition to apoptosis. To confirm whether cfDNA concentrations and fragment patterns can be used as a biomarker for APL treated with ATO, further accumulative data are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arsenic TrioxideLeukemia, Promyelocytic, AcuteCell-Free Nucleic AcidsHumansMaleFemaleAgedChildOxidesAntineoplastic AgentsArsenicalsMiddle AgedCase-Control Studies

Stichwörter der Autor:innen

Cell-free DNAacute promyelocytic leukaemiaarsenic trioxideladder fragmentmicrotip electrophoresismutation analysis

Substanzen

Arsenic TrioxideCell-Free Nucleic AcidsOxidesAntineoplastic AgentsArsenicals

Autor:innen und Institutionen

  • Department of Legal Medicine, Shimane University Faculty of Medicine, Izumo, Japan.
  • Shimane Institute for Industrial Technology, Matsue, Japan.

ORCID-Profile: Junko Fujihara, Naoki Nishimoto

Förderung

  • Japan Society for the Promotion of Science
  • Grant-in-Aid for Scientific Research

Zitieren

APA

Fujihara, J., Nishimoto, N., & Takeshita, H. (2024). Plasma cell-free DNA in patients with acute promyelocytic leukaemia treated with arsenic trioxide. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine. https://doi.org/10.1177/00045632231216596

Vancouver

Fujihara J, Nishimoto N, Takeshita H. Plasma cell-free DNA in patients with acute promyelocytic leukaemia treated with arsenic trioxide. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine. 2024. doi:10.1177/00045632231216596

BibTeX
@article{Fujihara2024,
  author = {Fujihara, Junko and Nishimoto, Naoki and Takeshita, Haruo},
  title = {Plasma cell-free DNA in patients with acute promyelocytic leukaemia treated with arsenic trioxide},
  journal = {Annals of Clinical Biochemistry: International Journal of Laboratory Medicine},
  year = {2024},
  doi = {10.1177/00045632231216596}
}
Kostenlos starten →